For pharmacists, from Drug Topics: News and features for pharmacists about clinical trials, newly approved drugs, and new practices in clinical pharmacy
February 15, 2010
By:Christine Blank, Contributing Editor
Medication therapy management interventions by community pharmacists reduced prescription drug costs by $35 per month on average.
 |
February 15, 2010
By:Leah Perry
The following months promise the appearance on the market of a diverse group of new drug therapies. Breakthroughs will include drugs for the treatment of Alzheimer's disease and cardiovascular disease.
|
February 15, 2010
By:Fred Gebhart, Contributing Editor
Most agents used for presurgical prophylaxis are not effective against MRSA. To reduce MRSA-related surgical site infections,says one expert, you need to prevent all SSIs.
|
February 15, 2010
By:Marcus Campbell, PharmD
This article provides a review of newer drugs available for the treatment of diabetes, a summary of clinical practice guidelines, and a discussion of recent clinical trials.
|
January 15, 2010
By:Christine Blank, Contributing Editor
A cluster-randomized controlled clinical trial carried out in six community-based family medicines has demonstrated that healthcare teams that included pharmacists helped improve patients' blood-pressure management.
|
January 15, 2010
By:Leah Perry
Categories to watch in this year's diverse drug pipeline include oral agents to treat multiple sclerosis and a host of new diabetes, cardiovascular, and pain-management products.
|
January 15, 2010
By:Fred Gebhart, Contributing Editor
FDA has announced that concomitant use of omeprazole (Prilosec, AstraZeneca, and Prilosec OTC, Procter & Gamble) and clopidogrel (Plavix, Sanofi Aventis/Bristol-Myers Squibb) can reduce the anti-clotting effectiveness of clopidogrel.
|
January 15, 2010
By:Kenneth R. Baker, BS Pharm, JD
When pharmacies are planning their quality assurance or continuous quality improvement plans, they need to determine whether their goals are strictly conformity with state and federal requirements, or something more.
|
January 15, 2010
By:Allana J. Sucher, PharmD, BCPS, Brandon J. Sucher, PharmD, CDE, Cristal Randall, PharmD candidate
This article reviews the etiologies, clinical presentation, and antimicrobial treatment options for upper respiratory tract infections. After reading this article, pharmacists should be able to recommend appropriate preventive measures, supportive agents, and treatment regimens for common URTIs.
|
| 
| Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
|
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION|
 | | | |
| How much professional information do you obtain through the Internet? | | | Less than 10% | | 9% | | | 10% to 25% | | 17% | | | 26% to 50% | | 24% | | | 51% to 75% | | 25% | | | More than 75% | | 25% | |
| |  | | | |
|
|
  Drug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.
Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.  | 
